Table 1 Baseline characteristics of the study population
Variables | Controls, n = 331 | Patients with IS, n = 328 | P value |
|---|---|---|---|
Age, years (± SD) | 60.8 (± 11.2) | 62.0 (± 11.4) | 0.18 |
Male/ Female (%) | 217 (65.6)/ 114 (34.4) | 232 (70.7)/ 96 (29.3) | 0.15 |
Hypertension, yes/no (%) | 62 (18.7)/269 (81.3) | 172 (52.4)/156 (47.6) | < 0.001 |
Type 2 diabetes, yes/no (%) | 26 (7.9)/305 (92.1) | 47 (14.3)/281 (85.7) | 0.008 |
Smoking, yes/no (%) | 86 (26.0)/245 (74.0) | 101 (30.8)/227 (69.2) | 0.17 |
TC, mmol/L | 4.77 ± 0.78 | 4.67 ± 1.13 | 0.19 |
TG, mmol/L | 1.33 ± 0.80 | 1.82 ± 1.57 | < 0.001 |
HDL-C, mmol/L | 1.52 ± 0.39 | 1.14 ± 0.33 | < 0.001 |
LDL-C, mmol/L | 2.34 ± 0.99 | 2.94 ± 0.95 | < 0.001 |
VLDL-C, mmol/L | 0.68 ± 0.50 | 0.85 ± 0.69 | < 0.001 |
Apo-A1, g/L | 1.77 ± 1.09 | 1.24 ± 0.26 | < 0.001 |
Apo-B, g/L | 0.76 ± 0.30 | 1.00 ± 0.30 | < 0.001 |